IRAK1 controls the activation of antigen-presenting cells (APCs) under inflammatory conditions, and suppressing IRAK1 may potentially reduce APC activation and alleviate acute graft-versus-host disease (aGVHD) [33]. The gene discussed is IRAK1; the disease is acute graft versus host disease.